Innate Pharma will hold its Annual General Meeting of Shareholders (“AGM”) on May 19, 2020.
In accordance with Article 4 of Covid-19 Ordinance, the AGM must be held without the shareholders and other persons entitled to attend being physically present. Shareholders are therefore invited to vote at the general meeting either by mail or by proxy.
The Notice of Meeting of this AGM was published on April 14, 2020, in the French official legal bulletin (“BALO”). It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM.
All documentation regarding this AGM will be published on the Company's website.